Clinical Trials Browser

Interventional × Lymphangioma × Clear all

NCT07477548 2026-03-17

A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies

Phase 2 Not yet recruiting

Arteriovenous Malformations, Hemangioendothelioma, Hemangioma, Lymphangioma, Nevus, Vascular Malformations

NCT05983159 2026-02-19

TARGET-VM

Phase 2 Recruiting

Arteriovenous Malformations, Lymphangioma, Skin Diseases, Vascular, Lymphangioma, Cystic, Lymphatic Abnormalities, Vascular Malformations

NCT05948943 2026-02-13

EPIK-L1

Phase 2/3 Recruiting

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities

NCT00975819 2026-01-06

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

Phase 2 Completed

61 enrolled 7 charts

Classical hematology

Tufted angioma, Lymphangioma, Thrombocytopenia

NCT06239480 2025-07-23

SELVA

Phase 3 Recruiting

Congenital Abnormalities, Lymphangioma, Lymphatic Abnormalities, Vascular Malformations

NCT06892964 2025-03-25

IReg-LM

Phase NA Recruiting

Lymphangioma, Lymphatic Abnormalities

NCT05050149 2025-01-17

Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations

Phase 2 Completed

12 enrolled 7 charts

Lymphangioma

NCT00010452 2015-03-25

Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

Phase 2/3 Completed

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities